Colfax Corporation (CFX): Price and Financial Metrics


Colfax Corporation (CFX): $43.97

-0.96 (-2.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CFX Stock Summary

  • CFX's current price/earnings ratio is 124.96, which is higher than 92.01% of US stocks with positive earnings.
  • Of note is the ratio of Colfax CORP's sales and general administrative expense to its total operating expenses; 82.54% of US stocks have a lower such ratio.
  • Over the past twelve months, CFX has reported earnings growth of -137.41%, putting it ahead of merely 14.41% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Colfax CORP are VMI, CTB, MWA, SXT, and AMWD.
  • CFX's SEC filings can be seen here. And to visit Colfax CORP's official web site, go to www.colfaxcorp.com.

CFX Stock Price Chart Interactive Chart >

Price chart for CFX

CFX Price/Volume Stats

Current price $43.97 52-week high $50.26
Prev. close $44.93 52-week low $21.76
Day low $43.75 Volume 285,517
Day high $45.33 Avg. volume 1,411,712
50-day MA $44.52 Dividend yield N/A
200-day MA $36.65 Market Cap 5.95B

Colfax Corporation (CFX) Company Bio


Colfax Corporation is a manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. The company was founded in 1860 and is based in Annapolis Junction, Maryland.

CFX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$43.97$6.3 -86%

We started the process of determining a valid price forecast for Colfax CORP with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Colfax CORP ranked in the 16th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for CFX, they are:

  • The company's compound free cash flow growth rate over the past 5.58 years comes in at -0.1%; that's greater than merely 13.97% of US stocks we're applying DCF forecasting to.
  • Colfax CORP's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
  • Relative to other stocks in its sector (Industrials), Colfax CORP has a reliance on debt greater than 70.41% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-86%
1%-86%
2%-86%
3%-86%
4%-86%
5%-86%

For other companies in the Industrials that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CFX, try AIR, EFX, THR, ACM, and KNL.


CFX Latest News Stream


Event/Time News Detail
Loading, please wait...

CFX Latest Social Stream


Loading social stream, please wait...

View Full CFX Social Stream

Latest CFX News From Around the Web

Below are the latest news stories about Colfax CORP that investors may wish to consider to help them evaluate CFX as an investment opportunity.

Is CFX Stock A Buy or Sell?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 887 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of December 31st, 2020. […]

Yahoo | April 12, 2021

Are Colfax Corporation's (NYSE:CFX) Mixed Financials Driving The Negative Sentiment?

With its stock down 11% over the past month, it is easy to disregard Colfax (NYSE:CFX). It seems that the market might...

Yahoo | April 7, 2021

DJO Invests in Next-Generation Augmented Reality Technology Primed for ASC Market Growth

DJO today announced a strategic investment in Insight Medical Systems, a technology company dedicated to wearable surgical navigation in orthopaedics.

Yahoo | March 30, 2021

Colfax (CFX) to Redeem $700M Worth Senior Notes Due 2024 & 2026

Colfax (CFX) to redeem $700 million worth of senior notes that are due to expire in 2024 and 2026. The move will help the company to lower its debt balance.

Yahoo | March 26, 2021

Colfax to redeem in full 6.000% senior notes due 2024 and $100M of 6.375% senior notes due 2026

Colfax Corporation ([[CFX]] -2.3%) has notified the holders its intention to redeem on April 24, 2021, $600M of its outstanding 6.000% senior notes due 2024 at 103% of the principal amount and $100M of the $400M outstanding of its 6.375% senior notes due 2026 at 106.375% of the principal amount....

Seeking Alpha | March 25, 2021

Read More 'CFX' Stories Here

CFX Price Returns

1-mo -1.72%
3-mo 9.62%
6-mo 36.47%
1-year 89.20%
3-year 35.25%
5-year 36.81%
YTD 14.98%
2020 5.11%
2019 74.07%
2018 -47.25%
2017 10.27%
2016 53.88%

Continue Researching CFX

Here are a few links from around the web to help you further your research on Colfax CORP's stock as an investment opportunity:

Colfax CORP (CFX) Stock Price | Nasdaq
Colfax CORP (CFX) Stock Quote, History and News - Yahoo Finance
Colfax CORP (CFX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.2273 seconds.